Covaxin's 50% effectiveness neither bad nor surprising, say

If there is a significant reduction in the severity of cases, 50 per cent is still a useful efficacy, it can decrease the load on poor healthcare infrastructure, Immunologist Bal told PTI.

Related Keywords

Faridabad , Haryana , India , Delhi , Wuhan , Hubei , China , New Delhi , Pune , Maharashtra , Bharat , Akshay Binayke , Amit Awasthi , Satyajit Rath , Ramachandran Thiruvengadam , Vineeta Bal , Centers For Disease , National Institute Of Virology , Translational Health Science , Indian Council Of Medical Research , World Health Organisation , Pfizer , Astrazeneca , Technology Institute , National Institute Of Immunology , Pune Indian Institute Of Science Education , India Institute Of Medical Sciences , Lancet Infectious Diseases , All India Institute , Medical Sciences , Indian Institute , Science Education , National Institute , Hyderabad Based Bharat Biotech , Virology Indian Council , Medical Research , Indian Council , Disease Control , New England Journal , Covaxin , Adults , Children , Vaccine Drive , Indian Experts , ,